Early-stage Respiratory Syncytial Virus vaccine trial begins
Phase 1 study will enroll a small group of healthy adult volunteers.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | National Institutes of Health (NIH) | Respiratory Medicine | Study | Vaccines